期刊
PHYTOTHERAPY RESEARCH
卷 28, 期 5, 页码 714-721出版社
WILEY
DOI: 10.1002/ptr.5048
关键词
curcumin; pentylenetetrazol; adenosine receptors; CHA; DPCPX; CPCA; CSC
资金
- Council of Scientific and Industrial Research (CSIR), Ministry of Human Resource Development, Government of India
Curcumin, obtained from Curcuma longa, has been in use for manifold human disorders. The present study explores the effect of curcumin against pentylenetetrazol (PTZ) seizure threshold in mice. The possible involvement of adenosine receptor(s) mechanism was also investigated. Minimal dose of PTZ (i.v., mg/kg) needed to induce different phases of convulsions were recorded as an index of seizure threshold. Curcumin (20-120mg/kg, p.o.) produced an increase in seizure threshold for convulsions induced by PTZ i.v. infusion. The anticonvulsant effect of curcumin (80mg/kg) was prevented by 8-phenyltheophylline (0.5mg/kg, i.p., non-selective adenosine receptor antagonist) and 8-cyclopentyl-1,3-dipropylxanthine (5mg/kg, i.p., adenosine A(1) receptor antagonist) but not by 8-(3-cholorostryl)caffeine (4mg/kg, i.p., adenosine A(2A) receptor antagonist). Further, 5-N-ethylcarboxamidoadenosine (0.005mg/kg, i.p., non-selective A(1)/A(2) receptor agonist), or N-6-cyclohexyladenosine (0.2mg/kg, i.p., adenosine A(1) receptor agonist), was able to potentiate the anticonvulsant action of curcumin. In contrast, 5-(N-cyclopropyl) carboxamidoadenosine (0.1mg/kg, i.p., adenosine A(2A) receptor agonist) failed to potentiate the effect of curcumin. This study demonstrated the anticonvulsant effect of curcumin against PTZ i.v. seizure threshold via a direct or indirect activation of adenosine A(1) but not A(2A) receptors in mice. Thus, curcumin may prove to be an effective adjunct in treatment of convulsions. Copyright (c) 2013 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据